BioAmber (BIOA) Misses Q3 EPS by 16c

BioAmber (NYSE: BIOA) reported Q3 EPS of ($0.16), $0.16 worse than the analyst estimate of $0.00. Revenue for the quarter came in at $3.3 million versus the consensus estimate of $6.75 million.

For earnings history and earnings-related data on BioAmber (BIOA) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• Samsara Inc (IOT) Tops Q2 EPS by 4c, Beats on Revenue; Offers Q3 Guidance
• UiPath Inc. (PATH) Reports In-Line Q2 EPS; offers guidance